Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial have?
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial has 51 citations in the OpenAlex counts ScholarIQ stores.
When was Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial published?
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial has 2023 year in the ScholarIQ index.
What is the open-access status of Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial?
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial?
The DOI for Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial is on the source record.
What is the PMID of Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial?
The PMID for Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial is on the source record.
What is the OpenAlex record for Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial?
The OpenAlex for Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial is on the source record.